Form 4: Myomo Inc. Executive Harry Kovelman Reports Stock Sale to Cover Tax Obligations

Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 6,590 shares of common stock on March 11, 2024, to cover income taxes resulting from the vesting of restricted stock units.

Summary

• On March 11, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 6,590 shares of the company's common stock.
• The sale was executed at a price of $3.51 per share.
• This transaction was conducted to cover income tax obligations arising from the vesting of restricted stock units on March 8, 2024.
• The sale was completed pursuant to an irrevocable election made by Kovelman on March 8, 2024.
• Following the transaction, Kovelman directly owns 133,727 shares of Myomo, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The sale of shares to cover tax obligations related to vesting equity is a common occurrence across various industries.
• There are no specific industry benchmarks directly comparable to this individual transaction, as it is specific to the individual's tax situation and equity holdings.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates